Results 141 to 150 of about 18,575 (296)

Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial

BJU International, Volume 135, Issue 4, Page 638-647, April 2025.
Objectives To evaluate the effect of intravesical alkalinised lidocaine as an anaesthetic treatment on procedural pain during intradetrusor onabotulinumtoxinA (BTX‐A) injections for overactive bladder. Patients and Methods This single‐centre, randomised, double‐blind, placebo‐controlled two period crossover trial was conducted on women scheduled for ...
Meryam El Issaoui, Marlene Elmelund, Niels Klarskov   +2 more
wiley   +1 more source

Provider variability in the intraoperative use of neuromuscular blocking agents: a retrospective multicentre cohort study. [PDF]

BMJ Open, 2021
Althoff FC, Xu X, Wachtendorf LJ, Shay D, Patrocinio M, Schaefer MS, Houle TT, Fassbender P, Eikermann M, Wongtangman K.   +9 more
europepmc   +1 more source

Effect of Administration of Neuromuscular Blocking Agents in Children With Severe Traumatic Brain Injury on Acute Complication Rates and Outcomes

, 2015
Katherine Chin, Michael J. Bell, Stephen R. Wisniewski, G.K. Balasubramani, Patrick M. Kochanek, Sue R. Beers, S. Danielle Brown, P. David Adelson   +7 more
openalex   +1 more source

Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: yes [PDF]

, 2015
Claude Guérin, Jordi Mancebo
openalex   +1 more source

Non‐canonical PKG1 regulation in cardiovascular health and disease

British Journal of Pharmacology, EarlyView.
It is well established that the cyclic GMP‐dependent protein kinase I (PKG1) is canonically activated by cyclic guanosine monophosphate (cGMP), enabling its regulation of vascular tone, cardiac function and smooth muscle homeostasis. However, diverse non‐canonical stimuli of PKG1 have also been identified.
Jie Su, Joseph Robert Burgoyne
wiley   +1 more source

Use of Neuromuscular Blocking Agents in Elderly Patients: A Narrative Review in Geriatric Medicine. [PDF]

Int J Gen Med
Radkowski P, Szewczyk M, Dabdoub T, Murthy R, Grabarczyk Ł.   +4 more
europepmc   +1 more source

Treatment approaches in posthypoxic myoclonus: A narrative review with expert opinion

Epilepsia, EarlyView.
Abstract Acute posthypoxic myoclonus (PHM) is a neurological complication that typically emerges within 12–48 h following cardiac arrest, often in comatose patients. It can present as generalized, multifocal, or focal myoclonus and has traditionally been associated with poor prognosis.
Marina Romozzi, Federico Tosto, David García‐Azorín, Luigi Francesco Iannone, Catello Vollono, Paolo Calabresi, Juan Luis Alcala‐Zermeno, Michael R. Sperling   +7 more
wiley   +1 more source

Age-Specific Pharmacology of Neuromuscular Blocking Agents: A Comprehensive Review. [PDF]

Med Sci Monit
Radkowski P, Kowalczyk K, Łęczycka A, Oniszczuk H, Grabarczyk Ł.   +4 more
europepmc   +1 more source

Neuromuscular blocker agents in mechanically ventilated patients with ARDS

, 2023
José Manuel Ramos
openalex   +2 more sources

Equine botulism

Equine Veterinary Journal, EarlyView.
Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Kali Slavik, Robert Whitlock, Amy Johnson   +2 more
wiley   +1 more source